NCT03727919 (TARGET) is a NA clinical trial of Exoskeleton-assisted gait training in Stroke, sponsored by Universiteit Antwerpen.

Who is sponsoring NCT03727919?

NCT03727919 is sponsored by Universiteit Antwerpen.

What drugs are being tested in NCT03727919?

Interventions in NCT03727919: Exoskeleton-assisted gait training.

What condition does NCT03727919 study?

NCT03727919 studies Stroke, Paresis, Gait, Hemiplegic.

Is NCT03727919 still recruiting?

NCT03727919 is currently completed. Last updated 13 April 2022.

Last reviewed 2022-04-13 · How we verify

NCT03727919: TARGET

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Exoskeleton-assisted Training to Accelerate Walking Recovery Early After Stroke: the TARGET Phase II Study

Completed NA Last updated 13 April 2022

What this trial tests

NA trial testing Exoskeleton-assisted gait training in Stroke in 19 participants. Completed in 7 February 2022.

Timeline

1 November 2018

Primary endpoint
7 February 2022

7 February 2022

Quick facts

Lead sponsor	Universiteit Antwerpen
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	19
Start date	1 November 2018
Primary completion	7 February 2022
Estimated completion	7 February 2022
Sites	3 locations across Belgium

Drugs / interventions tested

Exoskeleton-assisted gait training

Conditions studied

Stroke — all drugs for Stroke →
Paresis — all drugs for Paresis →
Gait, Hemiplegic — all drugs for Gait, Hemiplegic →

Sponsor

Universiteit Antwerpen — full company profile →

Who can join

Adults 18 to 80, any sex, with Stroke or Paresis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Phase II: Investigating the effects of additional robot-assisted gait training either initiated early (2 weeks post-stroke) or delayed (8 weeks post-stroke) after stroke onset.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Electromechanical-assisted training for walking after stroke.
Mehrholz J, Thomas S, Kugler J, Pohl M, et al · · 2020 · cited 146× · PMID 33091160 · DOI 10.1002/14651858.cd006185.pub5
Time Course and Mechanisms Underlying Standing Balance Recovery Early After Stroke: Design of a Prospective Cohort Study With Repeated Measurements.
Schröder J, Saeys W, Yperzeele L, Kwakkel G, et al · · 2022 · cited 11× · PMID 35265023 · DOI 10.3389/fneur.2022.781416
Exoskeleton-assisted training to enhance lower limb motor recovery in subacute stroke: does timing matter? A pilot randomized trial.
Schröder J, Yperzeele L, Embrechts E, Loureiro-Chaves R, et al · · 2024 · PMID 41542275 · DOI 10.3389/fstro.2024.1379083

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07356011 — Exoskeleton for Balance · NA · recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting

Other Universiteit Antwerpen trials

Trials by the same sponsor.

NCT07407569 — Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After H · Phase 2 · recruiting
NCT07355101 — Personalized Exercise Coaching to Improve Quality of Life in Pediatric IBD · NA · active not recruiting
NCT06962579 — The Effect of Personalized Exercise Interventions for the Prevention of Chemotherapy-induced Peripheral Neuropathy · NA · recruiting
NCT06999473 — Assessment and Treat Neglect Patients With a VR Application · NA · not yet recruiting
NCT07161531 — Test-retest Reliability of sEMG to Measure Fatigue in Adolescents · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03727919 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universiteit Antwerpen
Last refreshed: 13 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03727919.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing